Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: A possible mechanism of antidepressant-like effects of nicotine

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 4, 2010, Pages 503-509

  Vázquez Palacios, Gonzalo ^a   Hernández González, Marisela ^c   Guevara Pérez, Miguel Ángel ^c   Bonilla Jaime, Herlinda ^b  

^a UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Antidepressant; Depression; Fluoxetine; Nicotine; REM sleep; Selective serotonin uptake inhibitor; Sleep; Sleep wake cycle

Indexed keywords

FLUOXETINE; NICOTINE;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; TREATMENT DURATION; WAKEFULNESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; CIRCADIAN RHYTHM; DRUG INTERACTIONS; FLUOXETINE; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; SLEEP STAGES; TIME FACTORS; WAKEFULNESS;

RATTUS;

EID: 74449088995     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.004     Document Type: Article

References (71)

1. Adrien J. Neurobiological bases for the relation between sleep and depression. Sleep Med Rev 6 5 (2002) 341-351
2. Alkondon M., and Albuquerque E.X. Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion. J Pharmacol Exp Ther 313 2 (2005) 740-750
3. Armitage R., and Sussman N. Effects of fluoxetine on sleep architecture and quality of sleep in depressed patients. Prim Psychiatry 4 (1997) 34-37
4. Bakalian M.J., and Fernstrom J.D. Effects of l-tryptophan and other amino acids on electroencephalographic sleep in the rat. Brain Res 528 2 (1990) 300-307
5. Beasley Jr. C.M., Sayler M., Weiss A.M., and Potvin J.H. Fluoxetine: activating and sedative effects at multiple fixed doses. J Clin Psychopharmacol 12 5 (1992) 328-333
6. Berger M., van Calker D., and Riemann D. Sleep and manipulations of the sleep-wake rhythm in depression. Acta Psychiatr Scand Suppl 418 (2003) 83-91
7. Bertrand D. The possible contribution of neuronal nicotinic acetylcholine receptors in depression. Dialogues Clin Neurosci 7 3 (2005) 207-216
8. Blier P., and de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 (1999) 91S-98S
9. Boutrel B., and Koob G.F. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27 6 (2004) 1181-1194
10. Buckley M.J., Surowy C., Meyer M., and Curzon P. Mechanism of action of A-85380 in an animal model of depression. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 723-730
11. Chaput Y., Araneda R.C., and Andrade R. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur J Pharmacol 182 3 (1990) 441-456
12. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signaling. Trends Pharmacol Sci 25 6 (2004) 317-324
13. Dani J.A., and Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47 (2007) 699-729
14. Davila S.G., Hurt R.D., Offord K.P., Harris C.D., and Shepard Jr. J.W. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 150 2 (1994) 469-474
15. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
16. Domino E.F., and Yamamoto K. Nicotine: effect on the sleep cycle of the cat. Science 150 (1965) 637-638
17. Dorsey C.M., Lukas S.E., and Cunningham S.L. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 14 6 (1996) 437-442
18. Ferguson S.M., Brodkin J.D., Lloyd G.K., and Menzaghi F. Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharmacology (Berl) 152 3 (2000) 295-303
19. Gao B., Duncan Jr. W.C., and Werh T.A. Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology (Berl) 106 3 (1992) 321-329
20. George R., Haslett W.L., and Jenden D.J. A cholinergic mechanism in the brain stem reticular formation: induction of paradoxical sleep. Int J Neuropharmacol 5 (1964) 3541-3552
21. Giedke H., and Schwärzler F. Therapeutic use of sleep deprivation in depression. Sleep Med Rev 6 5 (2002) 361-377
22. Gillin J.C., Lardon M., Ruiz C., Golshan S., and Salin-Pascual R. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers. J Clin Psychopharmacol 14 4 (1994) 264-267
23. Gillin J.C., Rapaport M., Erman M.K., Winokur A., and Albala B.J. A comparison of nefazodone and fluoxetine on mood and an objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 58 (1997) 185-192
24. Hobson J.A., Stickgold R., and Pace-Schott E.F. The neuropsychology of REM sleep dreaming. NeuroReport 9 (1998) R1-R14
25. Hubbard J.E., and Gohd R.S. Tolerance development to the arousal effects of nicotine. Pharmacol Biochem Behav 3 3 (1975) 471-476
26. Jewet R.E., and Norton S. Effects of some stimulants and depressant drugs on the sleep cycle of the cat. Exp Neurol 15 (1966) 463-474
27. Kenny P.J., File S.E., and Rattray M. Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci 13 6 (2001) 1267-1271
28. Kerkhofs M., Rielaert C., De Maertelaer V., Linkowski P., Czarka M., and Mendlewicz J. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables. Int J Clin Psychopharmacol 5 (1990) 253-260
29. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274 (1995) 866-876
30. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., and Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352 2 (1995) 141-148
31. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 1 (2000) 110-122
32. Lena C., Popa D., Graille R., Escourrou P., Changeux J.P., and Adrien J. Beta2-containing nicotine receptors contribute to the organization of sleep and regulate putative micro arousals in mice. J Neurosci 24 25 (2004) 5711-5718
33. Lesch K.P., and Heils A. Serotonergic gene transcriptional control regions: targets for antidepressant drug development?. Int J Neuropsychopharmacol 3 1 (2000) 67-79
34. Maudhuit C., Jolas T., Lainey E., Hamon M., and Adrien J. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology 33 8 (1994) 1017-1025
35. Mayers A.G., and Baldwin D.S. Antidepressants and their effect on sleep. Hum Psychopharmacol 20 8 (2005) 533-539
36. McNamara D., Larson D.M., Rapoport S.I., and Soncrant T.T. Preferential metabolic activation of subcortical brain areas by acute administration of nicotine to rats. J Cereb Blood Flow Metab 10 1 (1990) 48-56
37. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maz-Flores A., and Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur J Pharmacol 360 (1998) 31-36
38. Monti J.M., and Jantos H. A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat. Int J Neuropsychopharmacol 23 (2005) 1-12
39. Monti J.M., and Monti D. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep. Life Sci 66 21 (2000) 1999-2012
40. Nakamura K., and Tanaka Y. Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology 158 (2001) 205-212
41. Newhouse P., Singh A., and Potter A. Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Curr Top Med Chem 4 3 (2004) 267-282
42. Nicholson A.N., and Pascoe P.A. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27 8 (1988) 597-602
43. Page F., Coleman G., and Conduit R. The effect of transdermal nicotine patches on sleep and dreams. Physiol Behav 88 4-5 (2006) 425-432
44. Pastel R.H., and Fernstrom J.D. Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat. Brain Res 436 1 (1987) 92-102
45. Picciotto M.R., Caldarone B.J., King S.L., and Zachariou V. Nicotine receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22 (2000) 451-465
46. Quattrocki E., Baird A., and Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 8 3 (2000) 99-110
47. Rasmussen K., and Czachura J.F. Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT1A agonist 8-OH-DPAT. Psychopharmacology (Berl) 133 4 (1997) 343-346
48. Romanelli M.N., Gratteri P., Guandalini L., Martini E., Bonaccini C., and Gualtieri F. Central nicotinic receptors: structure, function, ligands, and therapeutic potential. Chem Med Chem 2 6 (2007) 746-767
49. Rutter J.J., Gundlah C., and Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171 (1994) 183-186
50. Saint-Mleux B., Eggermann E., Bisetti A., Bayer L., Machard D., Jones B.E., et al. Nicotinic enhancement of noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area. J Neurosci 24 1 (2004) 63-67
51. Salin-Pascual R.J., Rosas M., Jimenez-Genchi A., Rivera-Meza B.L., and Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57 9 (1996) 387-389
52. Salin-Pascual R.J., Moro-Lopez M.L., Gonzalez-Sanchez H., and Blanco-Centurion C. Changes in sleep after acute and repeated administration of nicotine in the rat. Psychopharmacology (Berl) 145 2 (1999) 133-138
53. Savitz J., Lucki I., and Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88 1 (2009) 17-31
54. Semba J., Mataki C., Yamada S., Nankai M., and Toru M. Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry 43 (1998) 389-391
55. Seth P., Cheeta S., Tucci S., and File S.E. Nicotinic-serotonergic interactions in brain and behavior. Pharmacol Biochem Behav 71 (2002) 795-805
56. Sher L. Prenatal alcohol exposure, circadian rhythm, and serotonin. Med Hypotheses 63 6 (2004) 1081
57. Takeuchi E. Polygraphical study on the wakefulness-sleep cycle of the rat. Jpn J Psychol 41 (1970) 248-256
58. Thase M.E. Depression, sleep and antidepressants. J Clin Psychiatry 59 (1998) 55-65
59. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark Jr. E., Janowsky D.S., et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142 2 (1999) 193-199
60. Trivedi M.H., Rush A.J., Armitage R., Gullion C.M., Grannemann B.D., and Orsulak P.J. Effects of fluoxetine on the polysomnogram in out-patients with major depression. Neuropsychopharmacology 20 (1999) 447-459
61. Vasar V., Appelberg B., Rimon R., and Selvaratnam J. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers. Int Clin Psychopharmacol 9 3 (1994) 203-206
62. Vazquez J., Guzman-Marin R., Salin-Pascual R.J., and Drucker-Colin R. Transdermal nicotine on sleep and PGO spikes. Brain Res 737 1-2 (1996) 317-320
63. Vazquez-Palacios G., and Bonilla-Jaime H. Nicotine, acetylcholine receptors and neuropsychiatric disorders. Rev Neurol 39 12 (2004) 1146-1160
64. Vazquez-Palacios G., and Velazquez-Moctezuma J. Effect of electric foot shocks, immobilization and corticosterone administration on sleep-wake pattern in the rat. Physiol Behav 71 (2000) 23-28
65. Vazquez-Palacios G., Bonilla-Jaime H., and Velazquez-Moctezuma J. Antidepressant-like effects of acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol Biochem Behav 78 1 (2004) 165-169
66. Vazquez-Palacios G., Bonilla-Jaime H., and Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry 29 1 (2005) 39-46
67. Velazquez-Moctezuma J., Shalauta M., Gillin J.C., and Shiromani P.J. Microinjections of nicotine in the medial pontine reticular formation elicits REM sleep. Neurosci Lett 115 (1990) 265-268
68. Vogel G.W., Buffenstein A., and Minter K. Drug effects on REM sleep and endogenous depression. Neurosci Biobehav Rev 14 (1990) 4963-4981
69. Von Bardeleben U., Steiger A., Gerken A., and Holsboer F. Effects of fluoxetine upon pharmacoendocrine and sleep EEG parameters in normal controls. Int Clin Psychopharmacol 4 (1989) 1-5
70. Wilson S., and Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 65 7 (2005) 927-947
71. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23 8 (2003) 3176-3185